{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T06:01:23Z","timestamp":1785045683238,"version":"3.55.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Capsular warning syndrome (CWS), a rare subtype of transient ischemic attack, is associated with a high risk of progression to acute cerebral infarction. However, predictive factors for infarction and determinants of functional outcome remain inadequately defined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this retrospective study, we analyzed 89 CWS patients admitted between January 2021 and December 2024. Clinical, laboratory, imaging, and treatment data were collected. Patients were stratified into infarcted and non-infarcted groups based on DWI findings. Infarcted patients were followed for 90\u202fdays, with outcomes assessed using the modified Rankin Scale (mRS). LASSO regression was used for variable selection, followed by multivariable logistic regression to identify independent predictors of infarction and favorable 90-day outcomes (mRS 0\u20132).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 89 patients, 57 (64%) experienced infarctions. Independent predictors included elevated platelet count (OR\u202f=\u202f1.02, 95% CI: 1.01\u20131.04, <jats:italic>p<\/jats:italic>\u202f=\u202f0.002), higher NIHSS score (OR\u202f=\u202f1.96, 95% CI: 1.25\u20133.55, <jats:italic>p<\/jats:italic>\u202f=\u202f0.011), higher ABCD2 score (OR\u202f=\u202f1.86, 95% CI: 1.04\u20133.60, <jats:italic>p<\/jats:italic>\u202f=\u202f0.047), intracranial atherosclerosis (OR\u202f=\u202f10.5, 95% CI: 1.54\u201399.0, <jats:italic>p<\/jats:italic>\u202f=\u202f0.024), and male sex (OR\u202f=\u202f5.57, 95% CI: 1.32\u201327.9, <jats:italic>p<\/jats:italic>\u202f=\u202f0.024). Among 57 infarcted patients, tirofiban infusion was the only independent predictor of favorable outcome (OR\u202f=\u202f0.01, CI: 0.00\u20130.07, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In CWS, infarction risk is independently associated with platelet count, clinical severity, vascular pathology, and sex. Tirofiban may improve short-term outcomes in infarcted patients. Prospective multicenter studies are needed to validate these findings.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1617623","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T05:30:51Z","timestamp":1753680651000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Predictors of infarction and outcomes in capsular warning syndrome: a retrospective observational study"],"prefix":"10.3389","volume":"16","author":[{"given":"Rui-xi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"107120","DOI":"10.1016\/j.clineuro.2022.107120","article-title":"Stroke warning syndrome","volume":"213","author":"Sales","year":"2022","journal-title":"Clin Neurol Neurosurg"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1212\/wnl.43.5.957","article-title":"The capsular warning syndrome: pathogenesis and clinical features","volume":"43","author":"Donnan","year":"1993","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000319460","article-title":"Nineteen-year trends in risk factors, clinical characteristics and prognosis in lacunar infarcts","volume":"35","author":"Arboix","year":"2010","journal-title":"Neuroepidemiology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/clinchem\/46.2.307","article-title":"Effect of rheumatoid factor on cardiac troponin I measurement using two commercial measurement systems","volume":"46","author":"Onuska","year":"2000","journal-title":"Clin Chem"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.06.008","article-title":"Pontine warning syndrome: case series and review of literature","volume":"19","author":"Muengtaweepongsa","year":"2010","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jns.2011.10.007","article-title":"Callosal warning syndrome","volume":"314","author":"Nandhagopal","year":"2012","journal-title":"J Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1212\/WNL.0b013e31826c1af8","article-title":"Population-based study of capsular warning syndrome and prognosis after early recurrent TIA","volume":"79","author":"Paul","year":"2012","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000525954","article-title":"Capsular warning syndrome: features, risk profile, and prognosis in a large prospective TIA cohort","volume":"52","author":"Foschi","year":"2023","journal-title":"Cerebrovasc Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2019.0222","article-title":"Stroke warning syndromes","volume":"81","author":"Sen","year":"2020","journal-title":"Br J Hosp Med (Lond)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000511829","article-title":"Risk of ischemic stroke after an inpatient hospitalization for transient ischemic attack in the United States","volume":"55","author":"Garg","year":"2021","journal-title":"Neuroepidemiology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/ijs.12432","article-title":"Clinical characteristics and outcome of the capsular warning syndrome: a multicenter study","volume":"10","author":"Camps-Renom","year":"2015","journal-title":"Int J Stroke"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"omab129","DOI":"10.1093\/omcr\/omab129","article-title":"'Crescendo transient ischemic attack'-an uncommon presentation of a very common disease: a case report on capsular warning syndrome","volume":"2022","author":"Payus","year":"2022","journal-title":"Oxf Med Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12883-019-1522-0","article-title":"Capsular warning syndrome: clinical analysis and treatment","volume":"19","author":"He","year":"2019","journal-title":"BMC Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1177660","DOI":"10.3389\/fneur.2023.1177660","article-title":"Capsular warning syndrome and its clinical awareness and therapeutic approach: two case reports and a systematic review of the literature","volume":"14","author":"Mart\u00ednez","year":"2023","journal-title":"Front Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1161\/STROKEAHA.120.033551","article-title":"Intravenous tirofiban infusion after angioplasty and stenting in intracranial atherosclerotic stenosis-related stroke","volume":"52","author":"Baek","year":"2021","journal-title":"Stroke"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMoa2214299","article-title":"Tirofiban for stroke without large or medium-sized vessel occlusion","volume":"388","author":"Zi","year":"2023","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1080\/09537104.2019.1680826","article-title":"Platelet count and mean volume in acute stroke: a systematic review and meta-analysis","volume":"31","author":"Sadeghi","year":"2020","journal-title":"Platelets"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood-2004-11-4365","article-title":"Chimeric NK-receptor-bearing T cells mediate antitumor immunotherapy","volume":"106","author":"Zhang","year":"2005","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12640-009-9017-1","article-title":"A chronic iron-deficient\/high-manganese diet in rodents results in increased brain oxidative stress and behavioral deficits in the Morris water maze","volume":"15","author":"Fitsanakis","year":"2009","journal-title":"Neurotox Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1161\/01.cir.91.11.2742","article-title":"Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses","volume":"91","author":"Ajayi","year":"1995","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/23969873231219416","article-title":"European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke","volume":"9","author":"Wardlaw","year":"2024","journal-title":"Eur Stroke J"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/17474930221144911","article-title":"Cerebral small vessel disease: recent advances and future directions","volume":"18","author":"Markus","year":"2023","journal-title":"Int J Stroke"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/brain\/awh023","article-title":"Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction","volume":"127","author":"Hassan","year":"2004","journal-title":"Brain"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40265-019-01078-0","article-title":"Platelet glycoprotein IIb\/IIIa receptor inhibitor Tirofiban in acute ischemic stroke","volume":"79","author":"Yang","year":"2019","journal-title":"Drugs"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1161\/STROKEAHA.110.599662","article-title":"Safety of Tirofiban in acute ischemic stroke: the SaTIS trial","volume":"42","author":"Siebler","year":"2011","journal-title":"Stroke"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jama.2022.12584","article-title":"Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke: the RESCUE BT randomized clinical trial","volume":"328","author":"Qiu","year":"2022","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2503678","article-title":"Early Tirofiban infusion after intravenous thrombolysis for stroke","author":"Tao","year":"2025","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1552658","DOI":"10.3389\/fneur.2025.1552658","article-title":"Intravenous tirofiban in acute ischemic stroke patients not receiving reperfusion treatments: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Alqurashi","year":"2025","journal-title":"Front Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/svn-2018-000163","article-title":"Intravenous tirofiban therapy for patients with capsular warning syndrome","volume":"4","author":"Li","year":"2019","journal-title":"Stroke Vasc Neurol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e70070","DOI":"10.1111\/ene.70070","article-title":"Tirofiban benefits the outcome of stroke patients with large artery atherosclerosis achieving full reperfusion and high NIHSS scores","volume":"32","author":"Arboix","year":"2025","journal-title":"Eur J Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1617623\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T05:30:52Z","timestamp":1753680652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1617623\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":30,"alternative-id":["10.3389\/fneur.2025.1617623"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1617623","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"article-number":"1617623"}}